(#0307, proten epression in E.coli phase I ; #S0310, protein expression in baculovirus system phase I; #0308, protein expresskon in E. Coli phase II; #0312, protein expression in baculovirus system…
Ended Purchase Order Awarded Last action
- Contract number
- N3239816P0274
- Awardee
-
Promab Biotechnologies, Inc. UEI MNDNCKJR4WL9
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Richmond, CA 94804, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$11,440 | |
| Original award | $11,440 |
Description
(#0307, proten epression in E.coli phase I ; #S0310, protein expression in baculovirus system phase I; #0308, protein expresskon in E. Coli phase II; #0312, protein expression in baculovirus system phase II.
Quick answers
Who was awarded contract N3239816P0274?
N3239816P0274 was awarded to Promab Biotechnologies, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 16, 2016.
How much is contract N3239816P0274 worth?
The government has obligated $0 on N3239816P0274.
Was contract N3239816P0274 competed?
The extent of competition for N3239816P0274 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award